Related Experiment Video
Updated: Aug 15, 2025
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
3.4K
Calcific Aortic Valve Stenosis with Aging and Current Development in its Pathophysiology.
1Department of Cardiology, Northwell Health-Lenox Hill Hospital, New York, New York.
Summary
Aortic stenosis, a common heart condition in older adults, may be an active biological process, not just wear and tear. Understanding its pathophysiology could lead to new prevention strategies for this valvular heart disease.
Area of Science:
- Cardiology
- Geriatrics
- Pathophysiology
Background:
- Aortic stenosis is the most prevalent valvular heart disease in the elderly population.
- Symptomatic progression of aortic stenosis often leads to rapid clinical decline and sudden death without intervention.
- Current treatments like valve replacement alleviate symptoms but do not fully address left ventricular remodeling.
Purpose of the Study:
- To review and synthesize the latest research on the pathophysiology of aortic stenosis in the elderly.
- To explore the hypothesis that aortic stenosis is an active biological process.
- To identify potential targets for preventing the disease's progression.
Main Methods:
- Literature review of recent studies on aortic stenosis pathophysiology.
- Analysis of biological mechanisms underlying aortic stenosis development and progression.
- Synthesis of findings related to the elderly demographic.
Main Results:
- The review highlights evidence suggesting aortic stenosis involves active biological pathways, not solely passive degeneration.
- Pathophysiological insights point towards inflammatory and cellular processes contributing to valve calcification and stenosis.
- Understanding these mechanisms is crucial for developing preventative therapies.
Conclusions:
- Aortic stenosis in the elderly is increasingly viewed as a complex, active biological disease.
- Further research into its pathophysiology may unlock novel preventative strategies.
- Shifting focus from passive degeneration to active biology is key for future interventions.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
25
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
01:15Aortic Regurgitation I: Introduction
24
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
24
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
41
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
41
01:25Aortic Regurgitation III: Medical Management
32
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
01:27Mitral Valve Prolapse I: Introduction
31
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
31
01:26Mitral Stenosis III: Medical Management
16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16